Beaufort Interviews

Jubilee Platinum

Beaufort TV | Mining | 13/07/2017

On Thursday, 13th July 2017 Leon Coetzer, CEO of Jubilee Platinum (JLP.L) answered questions posed by private investors at the Beaufort offices.


Katoro Gold

Beaufort TV | Mining | 26/05/2017

On Friday, 26th May 2017 Louis Coetzee, Executive Chairman of Katoro Gold (KAT.L) answered questions posed by private investors at the Beaufort offices.


Edison TV Interviews


Edison TV | Media | 26/07/2017

Martin Boddy, CEO of Jaywing (JWNG.L), describes the components of the business and how it is differentiated from other marketing services groups. He also talks through last year's acquisitions and what they are bringing to the group. Martin also discusses the opportunities for scaling up and his view on the current state of the market.

Jaywing is an agency and consulting business in the marketing services sector, with its HQ in Sheffield. It operates in the UK and Australia and specialises in the application of data science, with one in 10 of its 650+ people a data scientist. Over 60% of its contracted revenues are recurring, with one in three of its top 50 blue-chip clients buying more than one service line.


Tungsten Corporation

Edison TV | Financial Services | 25/07/2017

In thess interviews CEO Richard Hurwitz and CFO David Williams discuss Tungsten's (TUNG.L) operational and financial performance in the year to 30 April 2017. They also talk about the development of Tungsten in future, with further client engagement, helping buyers and suppliers to manage their accounts payable and receivable (AP and AR) better, plus internal efficiencies and a focus on technology and innovation.

Tungsten Corporation operates a global e-invoicing network, reducing the costs in time and money associated with paper-based invoicing. It also provides value-added services such as spend analytics to help buyers on its network save money, and invoice financing to suppliers to enable them to receive early payment on their invoices.


Osirium Technologies

Edison TV | Technology | 25/07/2017

David Guyatt, CEO of Osirium Technologies (OSI.L), introduces us to the business. He explains the security challenges that Osirium's technology seeks to address, the growth of the privileged access management software market and how Osirium's solutions are differentiated from incumbent providers. David highlights the key achievements since the IPO in April 2016, describes the company's channel strategy, and outlines some of management's key objectives for the coming year.

Osirium Technologies is an early stage, UK based, Software-as-a-Service (SaaS) cyber security company. The company's software protects users against both external and internal cyber threats through active management of so called 'privileged users', thereby limiting and controlling access to IT infrastructure and systems.


Picton Property Income

Edison TV | Financials | 13/07/2017

Michael Morris, CEO of Picton Property Income (PCTN.L), discusses the recent FY17 results, which showed a 6% increase in NAVPS and a 30% improvement in income profit. Michael discusses the main drivers of the increases in earnings and NAV during the year. He looks at how having an exposure to a weaker London market did not hinder returns during the year. Part of the reason for this was Picton's sector focus and Michael explains that there is currently a bias towards industrial assets and away from retail. He goes on to look at how Picton's performance compares with the main benchmark index over the short and longer term. Picton is an internally managed company and Michael talks through the advantages of this structure and its effect on long-term performance. Finally, he explains what the strategy of being "occupier-focused and opportunity-led" means in practice for Picton's tenants and shareholders.

Picton Property Income Limited is an internally managed investment company, which invests in commercial property across the United Kingdom. Established in 2005, it has a main market listing on the London Stock Exchange.



Edison TV | Consumer | 10/07/2017

Phil Maudsley, CEO of Findel (FDL.L), and Stuart Caldwell, Acting CFO discuss where the company stands on its strategic journey to become an online-driven value retailer through its Express Gifts division and the Studio brand. Significant progress has recently been logged, with the online proportion of orders jumping to 63%, and recent younger customers placing up to 90% of their first orders online. Phil also discusses the increasing use of Far East based production, not only for Express but in the Education division, where it is part of a strategy to improve competitiveness. Stuart also explains the use of debt as part of the company's consumer credit model.

Findel comprises market-leading businesses in the UK online value retailing and education supplies markets. The company's objective is to develop sustainable growth in a marketplace for value-conscious customers who are rapidly moving their purchases online.


IG Design Group

Edison TV | Consumer | 04/07/2017

Paul Fineman, CEO, describes IG Design Group's (IGR.L) business activities and highlights the group's competitive advantages. He then discusses last year's acquisition of Lang in the US, how it has added complementary products and customers and progress on its integration. He also comments on how the financial performance of the group has developed over the last few transitional years and the current priorities for the allocation of capital.

IG Design Group designs, manufactures, sources and distributes products to retailers across the world. These are in the categories of Celebrations (gift packaging, greetings cards and partyware), Stationery and Creative Play (design-led gifts) and Gifting (themed and design-coordinated giftware).


FreeAgent Holdings

Edison TV | Technology | 30/06/2017

FreeAgent's (FREE.L) CEO, Ed Molyneux, introduces FreeAgent. He explains the company's competitive positioning within the UK accountancy software market and describes how it is leveraging accountants as the company's channel partners. Looking ahead, he explains how HMRC's forthcoming Making Tax Digital initiative should become a tailwind for FreeAgent and why he believes that the company has ample headroom to continue growing in the UK market. He rounds up by explaining which key metrics investors should look for in FreeAgent as a pure SaaS business and the key milestones for the year ahead.

FreeAgent is a provider of cloud-based, Software-as-a-Service (SaaS) accounting software solutions and mobile applications designed specifically for UK micro-businesses (defined as sole traders and companies with fewer than 10 employees) and their accountants.


Seneca Global Income & Growth Trust

Edison TV | Investment Trusts | 27/06/2017

Seneca Global Income & Growth Trust (SIGT.L) was launched in 2005 and adopts a 'Multi-Asset Value Investing' approach, aiming to generate income and capital growth with low volatility by investing in a multi-asset portfolio of equities, fixed income and specialist assets. Since January 2012, SIGT's performance has been benchmarked against three-month Libor +3%. Annual dividends have increased each year since 2013. On 1 August 2016, SIGT adopted a discount control mechanism aiming to ensure that its share price trades very close to NAV.

In this webcast, chief investment officer Peter Elston and senior fund manager Alan Borrows comment on SIGT's FY17 annual results. They highlight notable changes in asset allocation over the last 12 months and a few new additions to the portfolio. Elston and Borrows then comment on why they believe that SIGT is becoming increasingly popular to a wider audience and about the discount control mechanism that was introduced in 2016.


BB Healthcare Trust

Edison TV | Investment Trusts | 26/06/2017

Paul Major, fund manager of BB Healthcare Trust (BBH.L) (launched December 2016), gives an overview of the investment trust and how it sits alongside manager Bellevue Asset Management's long-established BB Biotech fund. He explains how the high-conviction strategy differs from peers, not just in its concentrated portfolio drawn from across the healthcare universe, but also in its 3.5% distributions and annual redemption facility. Major goes on to explore why investors should consider looking at the healthcare sector, which is supported by scientific innovation and demographic change, and looks ahead to the rest of the year, a period in which he expects fundamentals for the sector to reassert themselves following a period where political debate has dominated the headlines.

BB Healthcare Trust (BBH) is an investment trust concentrating on the global healthcare sector. It holds a focused and actively managed portfolio of a maximum of 35 investments chosen for their capital growth potential. Structured as a UK-listed investment trust, the fund targets an annual dividend of 3.5% of NAV, which it manufactures largely from capital returns rather than being constrained by investing in high-yielding stocks. It offers an annual redemption facility as a means of minimising any potential discount to NAV.


Green Dragon Gas

Edison TV | Oil & Gas | 05/05/2017

2017 is likely to be a critical year for Green Dragon Gas (GDG.L) as management works to deliver on several milestones that will enable a step-up in activity levels. In this interview, CEO Randeep Grewal talks about the challenges and milestones for the year ahead. We were encouraged by the CNPC approval and submission of the GCZ CBM Block overall development plan (ODP) in April. Execution of supplementary agreements and GSS ODP submission would provide an incremental reserve base for GDG to leverage in order to refinance outstanding bonds and fund further drilling activity. With regard to funding, GDG states that it has multiple term sheets for mezzanine and RBL funding on hand, which should enable the company to refinance upcoming debt commitments. Our research looks at GDG under a range of scenarios, including an un-funded minimal-capex case and a base case that assumes access to RBL funding in 2017.



Edison TV | Industrials | 03/05/2017

Dialight (DIA.L) is leading the energy-efficient LED lighting revolution around the world for industrial and hazardous applications. It is committed to the continuing development of LED lighting solutions that enable its customers to lower their energy usage and carbon dioxide emissions, reduce maintenance costs and improve safety.

In this webcast, Michael Sutsko, who joined Dialight as CEO in June 2015, explains why LED lighting is particularly appropriate for use in industrial and hazardous applications, and the advantages accruing to Dialight of being one of the first movers in these segments. He describes the strategic review he instigated on joining the company and how this benefited FY16 results. Michael concludes by talking about the actions that management is taking to ensure that Dialight retains its leadership position in LED lighting and continues to benefit from the long-term opportunity that the sector presents.


Learning Technologies Group

Edison TV | Technology | 11/04/2017

Jonathan Satchell, CEO of Learning Technologies Group (LTG.L), discusses the group's background and its ambitions. LTG recently announced FY16 results, which saw revenue up 42%, adjusted EBITDA up 77% and adjusted EPS up 57%, and Jonathan talks through the industry dynamics that are driving this growth. He discusses the rationale for buying NetDimensions and explains how it will fit within the broader group. He discusses the 100-day plan for achieving cost synergies from NetDimensions and the impact it is likely to have on the business in the longer term. Finally, he outlines the key milestones that investors should expect from LTG over the next 12 months.

LTG was historically a professional services group, building bespoke content for corporate training environments, either in conjunction with the customer's own learning management system (LMS) or an open source LMS such as Moodle. In recent years, it has developed and acquired its own suite of specialist learning technology software solutions, including gomo (an authoring tool) and Rustici (enables interoperability across different technology standards). Most recently, it has acquired NetDimensions, which gives the group its own proprietary LMS.


Nanoco Group

Edison TV | Technology | 05/04/2017

Dr Michael Edelman, CEO of Nanoco Group (NANO.L), discusses the progress the company is making towards securing its first commercial orders and in securing a strong position in the display supply chain with its key partners Merck, Dow and Wah Hong. He discusses progress for Nanoco's quantum dots in applications outside TV display, particularly the high-end PC monitor market, but also in lighting, healthcare and solar technologies. He also provides insight into the company's cash levels and funding position and discusses the key milestones that investors should look for in the remainder of the company's fiscal year and beyond.

Nanoco is the leading commercial supplier of cadmium-free quantum dots – fluorescent semiconductor nanoparticles that absorb or re-emit different colours of light depending on the size of the particle. Quantum dots can be used in a number of different applications including TV displays, lighting, medical applications and solar power. Display is the most advanced of these applications, where quantum dots can provide better picture quality and better efficiency than competing LCD or OLED screens.


Regional REIT

Edison TV | Property | 04/04/2017

Regional REIT (RGL.L) owns a commercial property portfolio of predominantly offices and light industrial units located in the regional centres of the UK. The recently published FY16 results covered the first full year of trading since the IPO in November 2015 and showed good progress on portfolio and rent roll growth, rebalancing the portfolio (towards England and Wales and to the office and industrial sectors), debt reduction and the delivery of attractive returns. The c 8.1% prospective dividend yield is the highest in the sector, supported by rents from a portfolio of c £630m following the acquisition of a portfolio from Conygar after the year end.

Stephen Inglis is the group property director and chief investment officer of London & Scottish Investments, which is the asset manager to Regional REIT, as well as being a non-executive director of Regional itself. In this interview he discusses the results, strategy and the outlook for regional property.


EMIS Group

Edison TV | Software & Computer Services | 16/03/2017

EMIS Group (EMIS.L) is a clinical software supplier to the UK healthcare market. The company was originally established to serve the GP market, where it has a dominant position with a market share of 55% of UK GP practices. It has expanded from this position to create a broad range of products serving the community, child and mental healthcare (CCMH) market, the acute sector, and community pharmacies (where it has c 37% share) as well specialist software and screening services for diabetic retinopathy. The company' strategy is to provide connected healthcare solutions to facilitate patient-centric care.

In this video, CEO Chris Spencer reviews the company's 2016 results, with a discussion of the performance at a divisional level. He explains the pressures on the NHS to match funding to the ever increasing demand for services, and details how the company is reacting to this, including the reorganisation of the Primary, CCMH and Secondary Care businesses into one unit. He describes the company's plans to develop the Patient online healthcare information business. Finally, he discusses the current trading environment and gives his views on the company's short and long-term outlook.



Edison TV | Media | 13/03/2017

7digital provides white-label platform services and solutions that enable businesses to provide end-to-end digital music services to their customers. Its platform provides the infrastructure that supports high resolution audio download and streaming services, together with the rights to more than 50 million music tracks and curation expertise to enable businesses to offer comprehensive digital music services to their clients. As well as providing these B2B services, 7digital runs its own online music shop and provides music radio programming for broadcasters including the BBC. Its global customer base comprises leading consumer brands, mobile carriers, broadcasters, equipment manufacturers and retailers including Panasonic, Onkyo, Cdiscount, and Electric Jukebox. The company was founded in 2004, listed on AIM in 2015 following the merger with radio group UBC and now employs c 125 FTEs through its offices in London, San Francisco, Manchester, Lille, Paris and Auckland.

In this interview CEO Simon Coles presents the 2016 results highlights, notably the move to EBITDA profitability in Q416 and strong growth in high margin licensing revenues in H216. It is this momentum, on a largely fixed cost base that underpins his confidence that 7digital will move to profitability across 2017as a whole. Cole outlines the rationale behind the proposed acquisition of its largest European competitor 24-7, which along-side scale and synergy brings a significant customer and strategic investor to 7digital via 24-7's parent company, MediaMarktSaturn. The digital music market has changed considerably over the last few years but remains ripe for disruption as a significant share of the market is still not served by the flat fee consumer subscription services. Cole explains why 7digital is well placed to share in the next phase of the industry's growth. With a leading position in a dynamic market and a management team experienced at integrating acquisitions he sees a significant opportunity for investors in 7digital.


Kainos Group

Edison TV | Technology | 10/02/2017

CEO Brendan Mooney outlines the main activities of the company's two divisions, Digital Services and Digital Platforms. He discusses growth prospects by division, including the growing number of opportunities in Germany, Benelux, Australia and the US. He explains the company's approach to product development and M&A. With the success of the business highly dependent on the ability to hire and retain well-qualified staff, he discusses the company's approach to hiring. Finally, he outlines the key milestones for investors to track over the next year.



Edison TV | Technology | 17/01/2017

CFO Erik Miller, who joined the company in the summer, gives an overview of his career before WANdisco (WAND.L) and explains why the company's replication technology and the IBM partnership were key attractions for joining the business. He discusses his key priorities for the near term and how the dynamics of WANdisco's economic model have evolved over 2016. He also describes the key financial metrics that investors should be looking for as the company executes on his plan.



Edison TV | Technology | 17/01/2017

CEO David Richards discusses recent developments in the big data marketplace and the relevance to WANdisco (WAND.L). He discusses the strong progress being made in the partnership with IBM, through which WANdisco signed a $1m deal with a major automotive manufacturer in Q4, and the strategic importance of the Amazon AWS partnership as more data migrates to the cloud. He describes the competitive environment for the WANdisco's technology and discusses emerging trends in terms of customer deployments of WANdisco's technology. He rounds up by summarising the key things that investors should expect from WANdisco in 2017.


Touchstone Innovations

Edison TV | Pharmaceuticals & Healthcare | 05/01/2017

Touchstone Innovations (IVO.L) (previously Imperial Innovations) is an investment company focused on building and creating companies formed from scientific research in the 'Golden Triangle' (the geographical region encompassing London, Cambridge and Oxford). Touchstone has 107 companies in its portfolio, with 45 accelerated growth companies where the company actively invests or takes a seat on the board. The top 10 valued companies comprise 60.4% (£202.5m) of the total portfolio value (£335.1m as of 31 July 2016). The majority of Touchstone's accelerated growth companies are in therapeutics (37%), while the continued push to broaden the portfolio focus particularly into technology is demonstrated by the second and third largest sectors comprising ICT and digital (24%) and engineering and materials (22%) companies. The remaining 15% of the accelerated growth portfolio is comprised of medtech and diagnostics companies.

In this webcast, CEO Russ Cummings discusses the significance of the recent rebranding and what it means for its broader investment strategy. He outlines the defining milestones in 2016 including the recently announced deal between PsiOxus and Bristol-Myers Squibb before finally giving an overview of what to expect from Touchstone Innovations in 2017.



Edison TV | General Industrials | 04/01/2017

Paragon (PAG.L) designs and manufactures advanced automotive electronics solutions as a direct supplier to the automotive industry. Products include sensors, acoustics, cockpit, electromobility and body kinematics. Production facilities are in Germany, the US and China.

In this webcast, paragon's CEO, Klaus Dieter Frers, discusses the long-term drivers for the group derived from automotive megatrends, while explaining how paragon's approach differs from its competitors. He also provides further information on how the additional funds received from the recent successful capital increase will be used and how this investment has driven the improved outlook and confidence for further growth in FY17 and beyond.



Edison TV | Healthcare | 20/12/2016

ReNeuron (RENE.L) is a UK clinical-stage biotech company developing allogeneic cell-based therapies. CTX neural stem cells are in development for ischaemic stroke disability (Phase II) and critical limb ischaemia (Phase I), and human retinal progenitor cells (hRPC) are being studied for retinitis pigmentosa (Phase I/II). ReNeuron is one of the pioneers in the field of stem cells, having developed proprietary technology platforms, notably based on the CTX neural stem cell line, derived and immortalised from a single donor cell. It is developing these multipotent adult stem cells specifically for allogeneic administration (as opposed to autologous procedures). The final product can be cryopreserved, stored and transported, with a simple procedure to prepare the cells for injection, so offering a genuine off-the-shelf, cell-based therapy. There is a clear clinical and commercial appeal, in that rather than addressing the symptoms of a disease, stem cell therapy seeks to address the cause of the condition, to effect repair or reversal of the disease through the regeneration of the affected tissue.

In this interview, CFO Michael Hunt explains the core technology of its business, the stem cell science it is developing, optimising and harnessing to create therapeutic products. He discusses the recently reported early Phase II clinical trial data for its CTX stem cell therapy in stroke and why this has given ReNeuron the confidence to commence a pivotal Phase II/III clinical trial in 2017. Finally, he also discusses expected newsflow resulting from the remainder of its pipeline – critical limb ischaemia (Phase I) and hRPC or retinitis pigmentosa (Phase I/II).


Gooch & Housego

Edison TV | Electronics & Electrical Equipment | 16/12/2016

Gooch & Housego (GHH.L) is a global leader in photonics technology. Its expertise extends from research through the development of prototypes to volume manufacturing and enables innovation and effective manufacturing in the aerospace & defence, industrial, life sciences and scientific research sectors.

In this webcast Gooch & Housego's CEO Mark Webster discusses how management has repositioned the industrials segment so that it is resilient to changes in demand from the manufacturing industry. He reviews the actions management has taken to move the group up the value-chain. He concludes by talking about investment in facilities and acquisitions going forward.


Seneca Global Income & Growth Trust

Edison TV | Financials | 01/12/2016

Seneca Global Income & Growth Trust (SIGT.L) was launched in 2005 and adopts a 'Multi-Asset Value Investing' approach, aiming to generate income and capital growth with low volatility by investing in a multi-asset portfolio of equities, fixed income and specialist assets. Since January 2012, SIGT's performance has been benchmarked against three-month Libor +3%. Annual dividends have increased each year since 2013. On 1 August 2016, SIGT adopted a discount control mechanism aiming to ensure that its share price trades very close to NAV.

In this webcast, chief investment officer Peter Elston and senior fund manager Alan Borrows discuss the new objectives for the trust that were adopted in 2012, an overview of how it is managed and their 'Multi-Asset Value Investing' approach. They highlight characteristics of some of the trust's holdings and where they are finding income. They then discuss the current asset allocation and which asset classes are looking the most/least attractive and highlight the recent adoption of a discount control mechanism.


The Brunner Investment Trust

Edison TV | Financials | 01/12/2016

The Brunner Investment Trust (BUT.L) was created in 1927, initially to manage the wealth of the Brunner family, one of the founding families of industrial giant ICI. It invests in UK and overseas equities and is managed by Lucy Macdonald at Allianz Global Investors. Its aim is to achieve long-term growth in capital and income. Dividends are paid quarterly and have risen year-on-year for 44 years. Over recent years the portfolio has become more concentrated, with c 70 stocks rather than 100+, and the focus on the UK has been reduced, a move reflected in the change in benchmark in 2008 from 60% UK/40% World ex-UK to a 50/50% split. The UK weighting has continued to fall and the board is exploring whether a new benchmark split would be more appropriate.



Edison TV | Media | 30/11/2016

Ebiquity is a leading independent media and marketing analytics company. The group structures its business into three practices: Media Value Management (MVM), Market Intelligence (MI) and Market Performance Optimisation (MPO). It provides services to 80% of the world's 100 largest advertisers. Headquartered in London, it has a global footprint, with offices in 14 countries and approximately 50% of revenues generated outside the UK.

In this interview, CEO Michael Karg outlines the group's core activities and key trends in the global advertising market, including the better use of data in marketing and how digital uptake has led to a more complex environment for advertisers, together with the need for more accountability. He explains how Ebiquity is well positioned to help its clients in this evolving landscape. Michael also discusses the potential implications of the high-profile report from the American Association of National Advertisers (ANA) into media transparency, which has drawn global attention and summarises the recommendations that Ebiquity, in collaboration with the ANA, has published. In this environment he believes there is an opportunity to accelerate growth, and presents Ebiquity's recently announced plan to do this. Michael finishes by explaining how, against a backdrop of a structurally growing market, Ebiquity is working to create a higher-quality, more robust business which, with its unique skill sets and global footprint, he expects to deliver sustained double-digit growth.


Middlefield Canadian Income

Edison TV | Investment Companies | 30/11/2016

Middlefield Canadian Income (MCT) was launched in 2006 aiming to provide a high level of sustainable dividends and long-term capital growth via investment primarily in Canadian and selected US equities. It is benchmarked against the S&P/TSX Composite High Dividend index in sterling terms and is a member of the FTSE All-Share index.

In this webcast, managers Dean Orrico and Rob Lauzon explain the attractiveness of the Canadian economy and what the result of the recent US election will likely mean for the trust. They highlight how the portfolio is split between Canadian and US equities and which sectors are looking more attractive from a growth, valuation and income perspective. They then highlight what they consider to be the differentiating features of the trust and its dividend policy and record.



Edison TV | Healthcare | 30/11/2016

Abzena (ABZA) is a UK life sciences group offering a range of services and technologies that enable its customers to develop safer and more effective biopharmaceutical products. Its core business is in its R&D service areas, which include immunology, protein engineering, ADC bioconjugation, synthetic chemistry and biomanufacturing.

In this video interview, CEO Dr John Burt discusses Abzena's integrated business model and how its services and approach distinguish it from other companies in the biopharmaceutical space. He also details how it is establishing itself in the US following its two acquisitions in 2015. He gives an update on the second part of its business model, Abzena inside products, and highlights the risk-free upside this could provide. John concludes by talking about Abzena's outlook for the next 24 to 36 months and the opportunities he sees for its future growth.


Entertainment One

Edison TV | Media | 22/11/2016

Entertainment One (eOne) is a leading international entertainment company that sources, selects and sells television, family, film and music content. In TV it is Canada's largest independent television producer and distributor, it has sizeable operations in the US and international distribution from the UK. Its Family content includes the UK's number one pre-school property, Peppa Pig. It also owns North America's largest independent music label, eOne Music. It is one of the world's largest multi-territory distributors of films with market-leading positions in the UK, Canada, Benelux, the US, Australia and Spain. Its content library, recently valued at $1.5bn, contains over 40,000 film and TV titles, 4,500 half-hours of TV programming and 45,000 music tracks.

In this video, eOne's CFO Giles Willits summarises the group's strategy to double the size of the business by 2020. He also outlines how the growth of global SVOD platforms is stimulating the demand for premium content of many genres and how eOne is positioned to take advantage of these trends. Giles updates on the first-half performance, which saw strong growth across all three core divisions and explains why he believes the outlook for the second half is also particularly strong. This is underpinned by a strong box office flowing through to the home entertainment market, the continued success of Family brands such as Peppa Pig and PJ Masks, which are growing strongly internationally. In addition, eOne Television and The Mark Gordon Company, which is seeing a very strong start for its new production, Designated Survivor, have excellent visibility in to the second half. Giles believes this strong outlook puts the group on track to deliver on its full year and medium-term plan.


Kiadis Pharma

Edison TV | Healthcare | 09/11/2016

Kiadis Pharma is developing T cell-based therapies to address the issues associated with haematopoietic stem cell transplantation (HSCT). The company is leveraging its Theralux technology to develop ATIR101 and ATIR201 as adjunct therapies to HSCT in leukaemia and thalassemia, respectively. Kiadis's Theralux platform allows the infusion of lymphocytes from a partially matching (haploidentical) family member to the donor as it eliminates cells that could react against the host's immune cells and cause complications such as graft vs host disease. On the back of Phase II data, Kiadis is aiming for accelerated filing of ATIR101 with the European Medicines Agency in Q117; a Phase III trial will start in H216. ATIR201 will start a Phase I/II trial in H216. Cash at end June 2016 was €23.7m, sufficient to fund operations until early 2018.

In this interview, CEO Dr Manfred Rüdiger explains the core technology of Kiadis's business and the immunotherapies it is developing, optimising and harnessing to create therapeutic products. He discusses problems associated with stem cell transplantation in blood disorders and how Kiadis Pharma is working to address them as well as the patient population and market opportunity for its products. He also provides an overview of the competitive advantages of Kiadis Pharma products with respect to the current standard of care and other competitors. Finally, he outlines the regulatory strategy and provides timelines for the next value inflection points.